A Game-Theoretic Model of International Influenza Vaccination Coordination

Influenza vaccination decisions in one country can influence the size of an outbreak in other countries due to interdependent risks from infectious disease transmission. This paper examines the inefficiency in the allocation of influenza vaccines that is due to interdependent risk of infection across borders and proposes a contractual mechanism to reduce such inefficiencies. The proposed contract is based on an epidemic model that accounts for intranational transmission and that from a source country where the dominant strain emerges. The contract reduces the overall financial burden of infection globally and improves the total number infected by seasonal influenza outbreaks. This is consistent with recent recommendations to improve pandemic preparedness. Numerical experiments demonstrate that the benefits of the contract can prevent millions of influenza cases and save tens of millions of dollars, and that the benefits are even greater when cross-border transmission is higher, even if cross-border transmission parameters have moderate estimation errors. This paper was accepted by Martin Lariviere, operations management.

[1]  M E Halloran,et al.  Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. , 1998, Statistics in medicine.

[2]  Andrew J. Schaefer,et al.  Optimizing the Societal Benefits of the Annual Influenza Vaccine: A Stochastic Programming Approach , 2011, Oper. Res..

[3]  I. Longini,et al.  An optimization model for influenza A epidemics , 1978 .

[4]  M Elizabeth Halloran,et al.  Population-wide benefits of routine vaccination of children against influenza. , 2005, Vaccine.

[5]  A. Nizam,et al.  Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.

[6]  Soo-Haeng Cho,et al.  The Optimal Composition of Influenza Vaccines Subject to Random Production Yields , 2010, Manuf. Serv. Oper. Manag..

[7]  Alan S. Perelson,et al.  Optimization of Influenza Vaccine Selection , 2005, Oper. Res..

[8]  Laurie Garrett,et al.  Sharing H5N1 Viruses to Stop a Global Influenza Pandemic , 2007, PLoS medicine.

[9]  Benjamin J Cowling,et al.  Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic , 2010, Proceedings of the National Academy of Sciences.

[10]  Sheldon H. Jacobson,et al.  A MULTI-ATTRIBUTE APPROACH FOR SETTING PEDIATRIC VACCINE STOCKPILE LEVELS , 2010 .

[11]  Peng Sun,et al.  Selfish Drug Allocation for Containing an International Influenza Pandemic at the Onset , 2009, Oper. Res..

[12]  Sarang Deo,et al.  Cournot Competition Under Yield Uncertainty: The Case of the U.S. Influenza Vaccine Market , 2009, Manuf. Serv. Oper. Manag..

[13]  Stephen E. Chick,et al.  Inferring Infection Transmission Parameters That Influence Water Treatment Decisions , 2003, Manag. Sci..

[14]  Fuqiang Zhang,et al.  Positive vs. Negative Externalities in Inventory Management: Implications for Supply Chain Design , 2005, Manuf. Serv. Oper. Manag..

[15]  Ralph L. Keeney,et al.  Repeated Commit-or-Defer Decisions with a Deadline: The Influenza Vaccine Composition , 2008, Oper. Res..

[16]  David Simchi-Levi,et al.  Supply Chain Coordination and Influenza Vaccination , 2008, Oper. Res..

[17]  Gérard P. Cachon,et al.  Game Theory in Supply Chain Analysis , 2004 .

[18]  Marc Lipsitch,et al.  Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy , 2009, PLoS medicine.

[19]  C. Macken,et al.  Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M E Halloran,et al.  Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. , 2000, Vaccine.

[21]  M. Brandeau,et al.  Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis. , 2003, Journal of health economics.

[22]  Peng Sun,et al.  Decentralized resource allocation to control an epidemic: a game theoretic approach. , 2009, Mathematical biosciences.

[23]  O. Diekmann Mathematical Epidemiology of Infectious Diseases , 1996 .

[24]  D. Owens,et al.  Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. , 2009 .